Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

Pierre Geborek, Anna Bladström, Carl Turesson, Anders Gülfe, I F Petersson, Tore Saxne, Håkan Olsson, Lennart Jacobsson

Research output: Contribution to journalArticlepeer-review

362 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds